Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Reddit Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $225 (market cap $29.97B), while Reddit Inc trades at $153.62 (market cap $29.52B). The key difference: Alnylam Pharmaceuticals, Inc. and Reddit Inc are close in size by market cap, and Reddit Inc is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| ALNY | RDDT | |
|---|---|---|
Market Cap | $29.97B | $29.52B |
Sector | Health | Media |
52-Week High | $491.22 | $270.71 |
52-Week Low | $205.48 | $121.84 |
Enterprise Value | $27.93B | $26.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALNY trades at $223.43, up 2.97% in 24 hours, with a bearish technical signal despite recent gains. The stock shows strong profitability with a 79.65% gross margin and 96.55% ROE, but valuation ratios like P/E of 38.54 are elevated. Recent Q2 2026 earnings missed estimates, and multiple law firms are investigating potential securities fraud, adding uncertainty.
Outlook is mixed: analyst consensus is bullish with a $370.07 price target, but risks include ongoing fraud probes and earnings volatility. Revenue growth is robust, projected to reach $4.8B in 2026, yet investors face headwinds from legal issues and technical bearishness.
Reddit (RDDT) trades at $153.46, down 3.3% in the past 24 hours amid bearish technical signals. The company demonstrates strong fundamentals with 61% YoY revenue growth in Q2 2026 and consistent earnings beats, though recent CEO share sales and search traffic concerns have pressured the stock. Technical indicators show resistance at $160 with support at $154, while fundamentals reveal robust profitability with 91.44% gross margins and 31.35% net income margins.
Despite near-term volatility, Reddit's growth trajectory and AI integration opportunities support long-term upside potential. The consensus price target of $220.25 implies 43% upside, though risks include user growth sustainability and competitive pressures. With no sell ratings from 28 covering analysts and strong institutional interest, the stock presents a compelling growth opportunity for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
